The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile
European Journal of Cancer2003Vol. 40(3), pp. 342–351
Citations Over TimeTop 10% of 2003 papers
M.C. Mathieu, Roman Rouzier, Antonio Llombart‐Cussac, Lucas Sidéris, Serge Koscielny, J.P. Travagli, G Contesso, Suzette Delaloge, M. Spielmann
Related Papers
- → Tubulolobular invasive breast cancer: A variant of lobular invasive cancer(1977)114 cited
- → Lobular carcinoma in situ and invasive lobular cancer of the breast(2005)47 cited
- [Second operation more frequent following breast-conserving treatment for invasive lobular than for invasive non-lobular carcinoma].(2009)
- → Abstract 4798: Genomic alterations in ERBB2 define a subset of pleomorphic invasive lobular breast cancer(2015)
- → Analysis of stage and clinical pathological characteristics of invasive lobular carcinoma with the 8th AJCC Cancer Staging system(2017)